Style | Citing Format |
---|---|
MLA | Ghanbarzadeh A, et al.. "Histopathological Evaluation of Nanocurcumin for Mitigation of Radiation-Induced Small Intestine Injury." Current Radiopharmaceuticals, vol. 16, no. 1, 2023, pp. 57-63. |
APA | Ghanbarzadeh A, Farhood B, Noodeh FA, Mosaed R, Hassanzadeh G, Bagheri H, Najafi M (2023). Histopathological Evaluation of Nanocurcumin for Mitigation of Radiation-Induced Small Intestine Injury. Current Radiopharmaceuticals, 16(1), 57-63. |
Chicago | Ghanbarzadeh A, Farhood B, Noodeh FA, Mosaed R, Hassanzadeh G, Bagheri H, Najafi M. "Histopathological Evaluation of Nanocurcumin for Mitigation of Radiation-Induced Small Intestine Injury." Current Radiopharmaceuticals 16, no. 1 (2023): 57-63. |
Harvard | Ghanbarzadeh A et al. (2023) 'Histopathological Evaluation of Nanocurcumin for Mitigation of Radiation-Induced Small Intestine Injury', Current Radiopharmaceuticals, 16(1), pp. 57-63. |
Vancouver | Ghanbarzadeh A, Farhood B, Noodeh FA, Mosaed R, Hassanzadeh G, Bagheri H, et al.. Histopathological Evaluation of Nanocurcumin for Mitigation of Radiation-Induced Small Intestine Injury. Current Radiopharmaceuticals. 2023;16(1):57-63. |
BibTex | @article{ author = {Ghanbarzadeh A and Farhood B and Noodeh FA and Mosaed R and Hassanzadeh G and Bagheri H and Najafi M}, title = {Histopathological Evaluation of Nanocurcumin for Mitigation of Radiation-Induced Small Intestine Injury}, journal = {Current Radiopharmaceuticals}, volume = {16}, number = {1}, pages = {57-63}, year = {2023} } |
RIS | TY - JOUR AU - Ghanbarzadeh A AU - Farhood B AU - Noodeh FA AU - Mosaed R AU - Hassanzadeh G AU - Bagheri H AU - Najafi M TI - Histopathological Evaluation of Nanocurcumin for Mitigation of Radiation-Induced Small Intestine Injury JO - Current Radiopharmaceuticals VL - 16 IS - 1 SP - 57 EP - 63 PY - 2023 ER - |